Literature DB >> 11080244

Interleukins and exercise.

M Gleeson1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11080244      PMCID： PMC2270173          DOI： 10.1111/j.1469-7793.2000.00001.x

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  4 in total

Review 1.  Special feature for the Olympics: effects of exercise on the immune system: modification of immune responses to exercise by carbohydrate, glutamine and anti-oxidant supplements.

Authors:  M Gleeson; N C Bishop
Journal:  Immunol Cell Biol       Date:  2000-10       Impact factor: 5.126

2.  Carbohydrate and the cytokine response to 2.5 h of running.

Authors:  S L Nehlsen-Cannarella; O R Fagoaga; D C Nieman; D A Henson; D E Butterworth; R L Schmitt; E M Bailey; B J Warren; A Utter; J M Davis
Journal:  J Appl Physiol (1985)       Date:  1997-05

3.  Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles.

Authors:  I H Jonsdottir; P Schjerling; K Ostrowski; S Asp; E A Richter; B K Pedersen
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

4.  Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

Authors:  A Steensberg; G van Hall; T Osada; M Sacchetti; B Saltin; B Klarlund Pedersen
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182
  4 in total
  27 in total

1.  The effects of carbohydrate supplementation during the second of two prolonged cycling bouts on immunoendocrine responses.

Authors:  Tzai-Li Li; Michael Gleeson
Journal:  Eur J Appl Physiol       Date:  2005-09-30       Impact factor: 3.078

2.  Skeletal muscle: not simply an organ for locomotion and energy storage.

Authors:  Graeme I Lancaster; Mark A Febbraio
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

3.  Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content.

Authors:  A Steensberg; M A Febbraio; T Osada; P Schjerling; G van Hall; B Saltin; B K Pedersen
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

4.  Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training.

Authors:  M Molanouri Shamsi; Z H Hassan; R Gharakhanlou; L S Quinn; K Azadmanesh; L Baghersad; A Isanejad; M Mahdavi
Journal:  Endocrine       Date:  2013-09-06       Impact factor: 3.633

5.  Plasma IL-6 concentration during ultra-endurance exercise.

Authors:  Linnea Wallberg; C Mikael Mattsson; Jonas K Enqvist; Björn Ekblom
Journal:  Eur J Appl Physiol       Date:  2010-11-27       Impact factor: 3.078

Review 6.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.

Authors:  Adam Steensberg; Christian P Fischer; Massimo Sacchetti; Charlotte Keller; Takuya Osada; Peter Schjerling; Gerrit van Hall; Mark A Febbraio; Bente Klarlund Pedersen
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

8.  Exercise Rehabilitation in Pediatric Cardiomyopathy.

Authors:  Gabriel Somarriba; Jason Extein; Tracie L Miller
Journal:  Prog Pediatr Cardiol       Date:  2008-04

Review 9.  New aspects of the hormone and cytokine response to training.

Authors:  Jürgen M Steinacker; Werner Lormes; Susanne Reissnecker; Yuefei Liu
Journal:  Eur J Appl Physiol       Date:  2003-11-08       Impact factor: 3.078

10.  Effects of allicin supplementation on plasma markers of exercise-induced muscle damage, IL-6 and antioxidant capacity.

Authors:  Quan-Sheng Su; Ye Tian; Jian-Guo Zhang; Hui Zhang
Journal:  Eur J Appl Physiol       Date:  2008-02-28       Impact factor: 3.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.